LIXTE BIOTECHNOLOGY HOLDINGS INC (LIXT)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$4.43-0.45%
Close 2026-07-28 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · LIXT
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Model as of — · Company calendar date is not available
LIXT — capital allocation — Unregistered Sales of Equity Securities
Dated 2026-07-02
Unregistered Sales of Equity Securities. The information set forth under
Why it matters: New partnerships could help Lixte grow and improve its business.
Supportive ifAnnouncement of at least one new strategic partnership that aligns with Lixte's goals.
Worry ifNo new partnerships announced in the next quarter.
Why it matters: New partnerships could drive growth and expand Lixte's market reach. This is a priority for management.
Supportive ifThere is news of at least one new partnership with a big industry player.
Worry ifNo new partnerships announced in the next quarter.
Why it matters: Completing the acquisition would make LIXTE stronger in the oncology market. This can help growth.
Supportive ifThe Liora Technologies deal will finish soon. It will be announced next quarter.
Worry ifThe acquisition is delayed or canceled. This will affect growth plans.
Why it matters: Approval is needed to change preferred stock to common shares. This affects funding.
Watch forStockholders said yes to changing Series D preferred stock.
Also watch forStockholders said no to the plan. This will hurt future funding.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$384 on $10,000 · ±3.8% | How much price usually moves either way. |
| Bad day | $816 loss on $10,000 · 8.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $5,456 loss on $10,000 · 54.6% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Raising capital is key for growth and needs after the merger.
Worry ifLIXTE says it raised over $5 million for its operations.
Less concerning ifLIXTE does not get more money, which causes problems for operations.
Why it matters: Completing this acquisition is key for LIXT's growth strategy. It could enhance their market position.
Supportive ifA press release confirms that Liora Technologies is now part of LIXT.
Worry ifNo news or delays in the deal process are shared.
Why it matters: NOMAD must fill its order backlog to grow after the merger.
Supportive ifNOMAD shows a big rise in order fulfillment rates or backlog conversion.
Worry ifNOMAD does not meet order fulfillment goals or the backlog keeps growing.
Why it matters: Successful integration will show if LIXTE can grow in the energy sector. It affects future plans.
Supportive ifManagement says the integration is on track. They are saving costs.
Worry ifManagement says integration is delayed. Costs are higher than expected.
Why it matters: Increased capacity in the Voyager fleet can lead to higher sales. This is essential for the company's growth.
Supportive ifVoyager fleet sales go up by at least 20% each year after the upgrade.
Worry ifSales from the Voyager fleet remain flat or decline year over year despite the capacity increase.
Why it matters: How LIXTE uses new capital will show its commitment to growth and managing losses.
Supportive ifManagement shares a clear plan for using the raised capital to support growth.
Worry ifManagement fails to provide a clear plan for the use of the raised capital.
Why it matters: More energy storage can help NOMAD compete better. This may lead to more sales.
Supportive ifNew orders or contracts for upgraded Voyager models may be announced next quarter.
Worry ifNo new orders or contracts for the Voyager models after the upgrade announcement.
Why it matters: Growth in revenue from the NOMAD fleet shows how well it is doing in the market.
Supportive ifNOMAD reports quarterly revenue growth exceeding 20% from the Voyager fleet.
Worry ifRevenue from the Voyager fleet remains flat or declines quarter over quarter.
Why it matters: Strong revenue growth would show that NOMAD's products are gaining traction in the market.
Supportive ifNOMAD's revenue grows more than 20% each quarter as it expands operations.
Worry ifNOMAD's revenue growth is under 5% each quarter, showing weak demand.
Why it matters: How well LIXTE integrates NOMAD will affect its growth in energy storage. Investors want to see better operations and more money coming in.
Supportive ifManagement says NOMAD's operations will show revenue growth in the next update.
Worry ifIf LIXTE keeps losing money and has no signs of better integration, it is a concern.
Why it matters: Issuing new shares can impact capital structure and investor confidence. It may fund growth.
Watch forAn announcement explains how money from new shares will be used for growth.
Also watch forNo clear plan for the use of proceeds is communicated after the share issuance.
Why it matters: The company is still losing money as it grows and integrates NOMAD. Smaller operating losses would show progress on this risk.
Supportive ifA quarterly report shows an operating loss smaller than $2.35 million.
Worry ifA quarterly report shows an operating loss of $2.35 million or more.
Why it matters: How LIXTE uses the new capital will affect its growth and operations.
Supportive ifManagement shares a clear plan for using the new capital for growth.
Worry ifLIXTE does not provide a clear plan for the new capital, causing uncertainty.
Why it matters: Issuing new shares could change capital structure and affect how investors feel.
Watch forAnnouncement of a new share issuance plan that is well-received by investors.
Also watch forNegative market reaction to the announcement of new share issuance.